Susan M. Henshall

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Innovative Methodology for Strengthening a Multidisciplinary Team Approach in Cities in Low- and Middle-Income Countries.

Innovative Methodology for Strengthening a Multidisciplinary Team Approach in Cities in Low- and Middle-Income Countries.

Journal: JCO global oncology

Published: October 17, 2022

C/Can City Engagement Process: An Implementation Framework for Strengthening Cancer Care in Cities in Low- and Middle-Income Countries.

C/Can City Engagement Process: An Implementation Framework for Strengthening Cancer Care in Cities in Low- and Middle-Income Countries.

Journal: JCO global oncology

Published: June 15, 2021

Cities as an Enabler for Strengthening Cancer Care.

Cities as an Enabler for Strengthening Cancer Care.

Journal: JCO global oncology

Published: June 15, 2021

Cancer care prioritised: Georgia expands access to cancer medicines.

Cancer care prioritised: Georgia expands access to cancer medicines.

Journal: The Lancet. Oncology

Published: October 09, 2020

City Cancer Challenge: Changing the Future of Cancer in Urban Populations.

City Cancer Challenge: Changing the Future of Cancer in Urban Populations.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 18, 2019

p53 nuclear accumulation as an early indicator of lethal prostate cancer.

p53 nuclear accumulation as an early indicator of lethal prostate cancer.

Journal: British journal of cancer

Published: January 24, 2019

An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.

An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.

Journal: International journal of cancer

Published: June 28, 2018

Cali, Colombia, Key learning City C/Can 2025: City Cancer Challenge.

Cali, Colombia, Key learning City C/Can 2025: City Cancer Challenge.

Journal: Colombia medica (Cali, Colombia)

Published: October 18, 2017

A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer.

A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 10, 2017

C/Can 2025: City Cancer Challenge, a new initiative to improve cancer care in cities.

C/Can 2025: City Cancer Challenge, a new initiative to improve cancer care in cities.

Journal: The Lancet. Oncology

Published: January 20, 2017

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer.

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer.

Journal: British journal of cancer

Published: September 04, 2014

The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo.

The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo.

Journal: International journal of oncology

Published: July 22, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026